Global muscle relaxant drugs market projected to grow to USD 5.91 billion by 2033

From GlobeNewswire: 2024-07-01 03:00:00

The Global Muscle Relaxant Drugs Market is projected to grow from USD 3.90 Billion in 2023 to USD 5.91 Billion by 2033, with a CAGR of 4.24%. Muscle relaxants are used to treat various disorders such as lower back pain. The market is driven by increased muscle strains, demand for effective treatment options, and activities of major players.

The skeletal muscle relaxant drugs segment is expected to dominate the global market. Oral administration is projected to grow rapidly due to benefits like patient compliance and ease of use. Hospital pharmacies are predicted to show high growth, driven by increasing hospital visits and an aging population. North America is set to lead the market due to a high prevalence of musculoskeletal issues.

The global muscle relaxant drugs market is segmented based on drug type, route of administration, and distribution channel. Major vendors include Amneal Pharmaceuticals LLC., Ipsen Biopharmaceuticals, Inc., and more. In November 2023, Lupin launched the generic version of Zemuron injection to relax skeletal muscles during surgery. The market is forecasted at global, regional, and country levels.

The Asia Pacific region is expected to grow rapidly due to increased research and development investments. The market is competitive with key players focusing on product development, partnerships, and strategic alliances. The growing aging population and rising cases of musculoskeletal issues are driving the demand for muscle relaxant drugs.



Read more at GlobeNewswire: Global Muscle Relaxant Drugs Market Size To Worth USD 5.91